VivoSense
The company will use the investment to expand its product specialist and client engagement teams.
Others receiving capital infusions include Altoida, which adds $14 million to its Series A round, and Zephyr AI, which rakes in $18.5 million.
Also: ActiGraph and VivoSense partner on wearables for drug trials; AristaMD adds Corstrata wound and ostomy specialists to remote consultation service.